Role of cysteine and glutathione in signal transduction, immunopathology and cachexia

BioFactors

Volumn 8, Issue 1-2, 1998, Pages 97-102

  Droge W ^a   Hack, V ^a   Breitkreutz, R ^a   Holm, E ^b   Shubinsky, G ^a   Schmid, E ^a   Galter, D ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GLUTATHIONE;

CACHEXIA; CONFERENCE PAPER; DISEASE SEVERITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOPATHOLOGY; MENTAL STRESS; MUSCLE ATROPHY; MUSCLE FATIGUE; NATURAL KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031827701     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520080117     Document Type: Conference Paper

References (32)

1. W. Dröge, H.-P. Eck, H. Näher, U. Pekar and V. Daniel, Abnormal amino acid concentrations in the blood of patients with acquired immune deficiency syndrome (AIDS) may contribute to the immunological defect, Biol. Chem. Hoppe-Seyler 369 (1988), 143-148.
2. H.-P. Eck, H. Gmünder, M. Hartmann, D. Petzoldt, V. Daniel and W. Dröge, Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients, Biol. Chem. Hoppe-Seyler 370 (1989), 101-108.
3. H.-P. Eck, C. Stahl-Hennig, G. Hunsmann and W. Dröge, Metabolic disorder as an early consequence of simian immunodeficiency virus infection in rhesus macaques, Lancet 338 (1991), 346-347.
4. R. Buhl, K. Holroyd, A. Mastrangeli, A.M. Cantin, H.A. Jaffe, F.B. Wells, C. Saltini and R.G. Crystal, Systemic glutathione deficiency in symptom-free HIV-seropositive individuals, Lancet 2 (1989), 1294-1298.
5. M. Roederer, F.J.T. Staal, H. Osada and L.A. Herzenberg, CD4 and CD8 T-cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses, Int. Immunol. 3 (1991), 933-937.
6. V. Hack, D. Schmid, R. Breitkreutz, C. Stahl-Hennig, P. Drings, R. Kinscherf, F. Taut, E. Holm and W. Dröge, Cystine levels, cystine flux and protein catabolism in cancer cachexia, HIV/SIV infection and senescence, FASEB J. 11 (1997), 84-92.
7. A. Groß, V. Hack, C. Stahl-Hennig and W. Dröge, Elevated hepatic γ-glutamylcysteine synthetase activity and abnormal sulfate levels in liver and muscle tissue may explain cysteine and glutathione levels in SIV-infected rhesus macaques, AIDS Res. Human Retrovir. 12 (1996), 1639-1641.
8. V. Hack, A. Groß, R. Kinscherf, M. Bockstette, W. Fiers, G. Berke and W. Dröge, Abnormal glutathione and sulfate levels after interleukin-6 treatment and in tumor-induced cachexia, FASEB J. 10 (1996), 1219-1226.
9. R. Kinscherf, V. Hack, T. Fischbach, B. Friedmann, C. Weiss, L. Edler, P. Bärtsch and W. Dröge, Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine, J. Mol. Med. 74 (1996), 393-400.
10. W. Dröge, A. Groß, V. Hack, R. Kinscherf, M. Schykowski, M. Bockstette, S. Mihm and D. Galter, Role of cysteine and glutathione in HIV infection and cancer cachexia. Therapeutic intervention with N-acetyl-cysteine (NAC), in: Antioxidants in Disease Mechanisms and Therapeutic Strategies, H. Sies, ed., Adv. Pharmacol., Vol. 38, Academic Press, 1997, pp. 581-600.
11. Miller, H. Sies, E.-M. Park and J.A. Thomas, Phosphorylase and creatine kinase modification by thiol-disulfide exchange and by xanthine oxidase-initiated S-thiolation, Arch. Biochem. Biophys. 276 (1990), 355-363.
12. V. Hack, A. Gross, A. Böhme, C. Stahl-Hennig and W. Dröge, Decrease of phosphocreatine level in skeletal muscle of SIV infected rhesus macaques correlated with decrease of intracellular glutathione, AIDS Res. Human Retrovir. 13 (1997), 1089-1091.
13. + lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection, Blood 86 (1995), 258-267.
14. + lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: Possible immunopathogenic role of oxidative stress, Blood 86 (1995), 1383-1391.
15. L.A. Herzenberg, S.C. de Rosa, J.G. Dubs, M. Roederer, M.T. Anderson, S.W. Ela, S.C. Deresinski and L.A. Herzenberg, Glutathione deficiency is associated with impaired survival in HIV disease, Proc. Natl. Acad. Sci. USA 94 (1997), 1967-1972.
16. D. Galter, S. Mihm and W. Dröge, Distinct effects of glutathione disulphide on the nuclear transcription factors-κB and the activator protein-1, Eur. J. Biochem. 221 (1994), 639-648.
17. M.L. Schmitz, T. Henkel and P.A. Baeuerle, Proteins controlling the nuclear uptake of NF-κB, Rel and dorsal, Trends Cell Biol. 1 (1991), 130-137.
18. R. Schreck, P. Rieber and P.A. Baeuerle, Reactive oxygen species intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1, EMBO J. 10 (1991), 2247-2258.
19. R. Schreck, B. Meier, D.N. Männel, W. Dröge and P.A. Baeuerle, Dithiocarbamates as potent inhibitors of NF-κB activation in intact cells, J. Exp. Med. 175 (1992), 1181-1194.
20. W. Dröge, Metabolische Störungen bei HIV-Infektion, in: Project News, Vol. 2, AIDS-Zentrum des Bundesgesundheitsamtes, Berlin, 1989, pp. 4-5.
21. W. Dröge, H.-P. Eck and S. Mihm, HIV-induced cysteine deficiency and T-cell dysfunction: a rationale for treatment with N-acetyl-cysteine, Immunol. Today 13 (1992), 211-214.
22. B. Akerlund, C. Jarstrand, B. Lindeke, A. Sönnerborg, A.-C. Akerblad and O. Rasool, Effect of N-acetyl-cysteine (NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial, Eur. J. Clin. Pharmacol. 50 (1996), 457-461.
23. R. Olivier, Flow cytometry technique for assessing effects of N-acetyl-cysteine on apoptosis and cell viability of human immunodeficiency virus-infected lymphocytes, Methods Enzymol. 251 (1995), 270-278.
24. E. Chieli and G. Mavaldi, Role of microsomal FAD-containing monooxigenase in the liver toxicity of thioacetamide S-oxide, Toxicology 31 (1984), 41-52.
25. 2+-dependent enzymes, J. Hepatol. 24 (1996), 460-467.
26. P.O. Seglen, Isolation of hepatocytes by collagenase permission, in: Methods in Toxicology. In Vitro Biological Systems, Vol. I, C.A. Tyson and J.M. Frazier, eds, 1993, pp. 234-243.
27. N. Sanz, C. Díez-Fernández and M. Cascales, Variations of hepatic antioxidant systems and DNA ploidy in rats aged 2 to 8 months, Biochim. Biophys. Acta 1315 (1996), 123-130.
28. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding, Anal. Biochem. 72 (1976), 248-254.
29. C.Y. Sum and C.B. Kasper, Mixed-function amine oxidase of the rat hepatocyte nuclear envelope. Demostration and effects of phenobarbital and 3-methylcholanthrene, Biochem. Pharmacol. 31 (1982), 69-72.
30. R.F. Del Maestro, W. McDonald and R. Anderson, Superoxide dismutase, catalase and glutathione peroxidase in experimental and human brain tumors, in: Oxygen Radicals and Their Scavenger Systems, Vol. 2, R. Greenwald and G. Cohen, eds, Elsevier, New York, 1983, p. 28.
31. J.C. Fernández-Checa, H. Takikawa, T. Horie, M. Ookhtens and N. Kaplowitz, Canalicular transport of reduced glutathione in normal and mutant eisai hyperbilirrubinemic rats, J. Biol. Chem. 267 (1992), 1667-1673.
32. N. Katz and K. Jungermann, Metabolic heterogeneity of the liver, in: Hepatic Transport and Bile Secretion: Physiology and Pathology, N. Tavoloni and P.D. Berk, eds, Raven Press, New York, 1993, pp. 55-70.